AUA: Upper Tract Urothelial Carcinoma (2023): Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
Line 89: | Line 89: | ||
==== Other ==== | ==== Other ==== | ||
*'''Cystoscopy to assess lower urinary tract''' | *'''<span style="color:#ff0000">Cystoscopy to assess lower urinary tract</span>''' | ||
** Essential component of the evaluation for patients with suspected UTUC due to the risk of concurrent lower tract urothelial cancer in this population | ** Essential component of the evaluation for patients with suspected UTUC due to the risk of concurrent lower tract urothelial cancer in this population | ||
* '''Upper tract endoscopy +/- biopsy of any identified lesion''' | * '''<span style="color:#ff0000">Upper tract endoscopy +/- biopsy of any identified lesion</span>''' | ||
**'''Diagnostic ureteroscopy''' | **'''<span style="color:#ff0000">Diagnostic ureteroscopy</span>''' | ||
***'''Indications for ureteroscopy or percutaneous endoscopy of the upper urinary tract (and when diagnostic and prognostic details are needed)''' | ***'''Indications for ureteroscopy or percutaneous endoscopy of the upper urinary tract (and when diagnostic and prognostic details are needed)''' | ||
***#'''Lateralizing hematuria''' | ***#'''Lateralizing hematuria''' | ||
***#'''Suspicious selective cytology''' | ***#'''Suspicious selective cytology''' | ||
***#'''Radiographic presence of a mass or urothelial thickening''' | ***#'''Radiographic presence of a mass or urothelial thickening''' | ||
***'''Document key descriptive features of UTUC including:''' | ***'''<span style="color:#ff0000">Document key descriptive features of UTUC including:''' | ||
***# '''Location (ureteral segment, renal pelvis, calyceal sites and lower tract)''' | ***# '''<span style="color:#ff0000">Location (ureteral segment, renal pelvis, calyceal sites and lower tract)''' | ||
***#'''Size''' | ***#'''<span style="color:#ff0000">Size''' | ||
***# '''Number''' | ***# '''<span style="color:#ff0000">Number''' | ||
***# '''Focality''' | ***# '''<span style="color:#ff0000">Focality''' | ||
***# '''Appearance (sessile, papillary, flat/villous)''' | ***# '''<span style="color:#ff0000">Appearance (sessile, papillary, flat/villous)''' | ||
***#Quality of visualization | ***# '''<span style="color:#ff0000">Quality of visualization </span''' | ||
***##Can impact the accuracy of endoscopic inspection (e.g., bleeding, difficulty in access, tumor location, artifacts from instrumentation) and should be documented in endoscopic reports. | ***##Can impact the accuracy of endoscopic inspection (e.g., bleeding, difficulty in access, tumor location, artifacts from instrumentation) and should be documented in endoscopic reports. | ||
***## These factors may guide further diagnostic testing and inform therapeutic interventions as well as provide points of comparison for subsequent ureteroscopic surveillance. | ***## These factors may guide further diagnostic testing and inform therapeutic interventions as well as provide points of comparison for subsequent ureteroscopic surveillance. |